Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
66 Cards in this Set
- Front
- Back
Pharmacological treatment of thyrotoxicosis?
MOA? |
THIONAMIDES:
1. Methimazole (MMI, Tapazole®) 2. Carbimazole (Neomercazole®) 3. Propylthiouracil (PTU) Drug of choice in Aust = Neomercazole® MOA = block activity of peroxidase --> prevent organification of I- --> prevent coupling of DIT/MIT to form T3/T4 PTU also blocks 5'-deiodinase (which converts T4 to T3) |
|
Indications and contraindications, advantages and disadvantages for radioactive iodine in thyrotoxicosis?
Does the thyroid status of the Pt matter? |
INDICATIONS: newly diagnosed Graves', relapsed Graves', toxic nodular hyperthyroidism
CONTRAINDICATIONS: pregnancy!! ADV: effective cure, outpatient, easily applicable, reduced goitre DISADV: slow effect over months, permanent hypothyroidism in >60% pts, deferral of pregnancy for 6mo NB: Pt should be euthyroid before commence treatment |
|
Indications and contraindications, advantages and disadvantages of SURGERY in thyrotoxicosis?
Does the thyroid status of the Pt matter? |
ABSOLUTE INDICATIONS: thyroid cancer, obstructive symptoms
RELATIVE INDICATIONS: failure or non-compliance with medical treatment, large goitre, pregnancy if clinically sig. drug side effects ADV: rapid control hyperthyroidism, 100% cure DISADV: invasive, expensive, permanent hypothyroidism, pain, scarring, complication risk (hypoparathyroidism, recurrent laryngeal n.) |
|
carbimazole
|
anti-thyroid drug
brand name = neomercazole |
|
Anti-thyroid drug regime
|
Therapy for hyperthyroidism generally starts at a high daily dose of 15 - 40mg continued until the patient has normal thyroid function, and then reduced to a maintenance dose of 5 - 15mg. Treatment is usually given for 12 - 18 months followed by a trial withdraw.
|
|
proylthiouracil
|
PTU = anti-thyroid drug
|
|
Treatment options hyperthyroidism
|
1. Anti-thyroid drugs
2. Radioactive iodine 3. Surgery |
|
Treatment for hypothyroidism
|
Thyroxine (levothyroxine)
|
|
Treatment options for pituitary tumour
|
1. surgery
2. radiotherapy 3. medical therapy |
|
medical therapy for prolactinoma.
MOA? |
dopamine receptor agonists (cabergoline).
MOA = binds D2 receptors. Inhibits synthesis and release of prolactin |
|
cabergoline = ?
|
potent dopamine receptor agonist on D2 receptors.
First-line agent in the management of prolactinomas |
|
octreotide = ?
|
Somatostatin analogue. Inhibits growth hormone. Also decreases tumour size of GH-secreting adenoma
|
|
medical therapy for GH-secreting adenoma?
|
Octreotide (somatostatin analogue)
|
|
medical therapy for corticotropin-secreting adenoma?
|
Ketoconazole (=anti-fungal agent that inhibits adrenal steroidogenesis). Not effective LT treatment. Usually reserved for patients unsuitable for surgery, or whose tumour has recurred post-surgery/radiation.
|
|
Ketoconazole = ?
|
anti-fungal agent that inhibits adrenal steroidogenesis
|
|
Radiation therapy for pituitary tumours. When and how is it used?
|
used in patients with recurrent or incompletely excised tumours, or patients that are unable to tolerate trans-sphenoidal surgery or medical therapy.
can be delivered by conventional external beam techniques, stereotactic radiosugery techniques, or isotope-labelled radiopharmaceuticals |
|
route used for surgical excision of pituitary adenoma? when wouldn't you use this route?
|
Transphenoidal microsurgery.
May have to use a transcranial route if tumour has extended into subfrontal, retrochiasmatic or middle cranial fossae |
|
describe route of administration for the following:
1. steroids 2. thyroid hormone 3. insulin 4. testosterone 5. gonadal steroids 6. DDAVP (desmopressin) |
1. steroids = oral
2. thyroid hormone = oral 3. insulin = subQ injection, pump 4. testosterone = depot IM injection 5. gonadal steroids = transdermal 6. DDAVP = intranasal spray, solution, oral |
|
DDAVP= ?
|
Desmopressin (trade names: DDAVP, Stimate, Minirin) is a synthetic replacement for vasopressin
|
|
Addison's disease treatment
|
Gluucocorticoid dose is 25 mg cortisone acetate mane and 12.5 mg nocte to mimic diurnal rhythm. Cortisone acetate is given at a minimum of two doses per day in Addison's disease. The half life of cortisone acetate is not long enough to sustain a once a day dose. In active individuals a third (midday) dose may be required.
PLUS fludrocortisone dose which is generally fixed |
|
Atosibar = ?
|
oxytocin antagonist used to prevent premature birth
|
|
syntocinon = ?
|
Synthetic oxytocin - used to induce labour or induce ejection of the placenta after birth
|
|
Glucocorticoid and mineralocorticoid relative potency of:
hydrocortisone dexamethasone prednisone betamethasone |
hydrocortisone G=1, M=1
prednisone G=4, M=0.25 betamethasone G=25, M<0.01 dexamethasone G=30-40, M<0.01 |
|
give doses of prednisone and dexamethasone equivalent to 20mg hydrocortisone
|
20mg hydro
= 5mg pred = 0.5mg dex |
|
what do you give in emergency anaphylaxis
|
endogenous hydrocortisone IV
|
|
what steroid do you give to prevent cerebral oedema?
|
dexamethasone
|
|
what are the basal needs of hydrocortisone per day?
when does this increase? |
20-25mg
mild illness x2-3 major stress x10 |
|
management of hypoglycaemia if conscious
|
"15 rule"
15g fast acting CHO (7 jelly beans, 150mL soft drink, 100mL glucozade, 3 tsp honey) 15g complex CHO (1 pce fruit, 1 slice bread, 2 buscuits) 15 mins later - re check BGL and if still low, give more fast acting |
|
management of hypoglycaemia if unconscious
|
IV injection 50% glucose (20-25mL)
IV injection glucagon then 15g complex CHO once awake |
|
after treatment of severe hypoglycaemia, what do you do if BGL are then really high?
|
BGL may rebound - do NOT treat hyperglycaemia aggressively in the first 24-48 hrs
|
|
rapid acting insulin = ?
|
analogues, absorbed rapidly, injection immediately before food, less likely to cause hypo
acting time = 2-3 hrs onset = 0-20 mins brands = Apidra, NovoRapid, Humalog |
|
short acting insulin = ?
|
solution of human insulin
onset of action w/in 30 min Duration 6-8 hrs brands = Actrapid, Humulin R |
|
intermediate acting insulin = ?
|
isophane aka NPH insulin
(complex of insulin bound to protamine which is a non-immunogenic fish protein) insulin released gradually into tissues onset = 1.5hr duration up to 24hr differs bw brands Brands = protaphane, humulin NPH |
|
Long acting insulin = ?
|
human insulin complexed with zinc
rarely used - replaced by analogues |
|
very long acting insulin = ?
|
analogue, replaced long-acting
there are 2: glargine and detemir 24 hr duration peak 3-14 hours Glargine = Lantus chemically modified so insoluble after injection Detemir = Levemir insulin binds to albumin from which it is slowly released |
|
management DKA
|
rehydration
restore normoglycaemia (insulin) look for infection replace K+ to prevent hypokalaemia monitor K+, glucose, HCO3-, creatinine hourly |
|
treatment candidiasis
|
topical, poorly absorbed antifungals
= IMIDAZOLE group, or AMPHOTERIUN or single oral dose imidazole occ. IV for serious infection |
|
treatment cellulitis
oral or IV? why? |
Oral therapy. For staph: FLUCLOXACILLIN or DICLOXACILLIN monotherapy.
Or can use cephalexin (didn't really understand what you're supposed to use) more severe or strep --> phenoxymethylpenicillin can give IV if unsuitable for oral, vital signs indicate septicaemia, rapidly progressing, immobile |
|
pharmacological treatment of obesity?
|
1. Phentermine (duromine)
2. Orlistat (Xenical) 3. Sibutramine (Meridia) |
|
phentermine = ?
|
chemically related to amphetamine - works predominantly on noradrenaline to reduce appetite.
central stimulant --> HTN, tachycardia, nervousness, headache, insomnia, tremor |
|
orlistat = ?
|
pancreatic lipase inhibitor
reduces the absorption of fat by roughly 30% not absorbed in bloodstream, not an appetite suppressant. can't eat high-fat meal or get incontinence and greasy stools. average weight loss 7-8% |
|
sibutramine = ?
|
combination noradrenaline and serotonin reuptake blocker.
no serotonin-releasing action therefore pharmacologically more like SSRIs. weight loss av. 5-8% has been ass'd with incr. BP - shouldn't be used in people with poorly controlled HTN |
|
oral hypoglycaemic therapy classes
|
1. Sulphonylureas
2. Biguanides 3. alpha-glucosidase inhibitors 4. meglitinides 5. thiazolidinediones 6. DPP-4 inhibitors |
|
Sulphonylureas = ?
SE? |
potentiate glucose-stimulated insulin release.
combine with sulfonylurea receptors of beta-cells. close potassium channels (like glucose!) depol of cell calcium influx insulin released SE= weight gain, hypoglycaemia |
|
Biguanides = ?
SE? Contraindications? Adv? |
Metformin is the only one currently available.
increased glucose uptake into skeletal muscle and fat appetite suppression (?gastric irritation) decreased intestinal glucose absorption decreased gluconeogenesis DOES NOT STIMULATE INSULIN SE= transient nausea, diarrhoea. Also LACTIC ACIDOSIS - check renal fn CONTRA = significant renal failure (excreted entirely by kidneys) ADV = prevents weight gain, may assist weight loss |
|
metformin = ?
|
Biguanide oral hypoglycaemic agent
|
|
T/F metformin stimulates insulin release
|
FALSE
|
|
T/F big side effect of metformin is risk of hypoglycaemia
|
false
|
|
alpha-glucosidase inhibitors = ?
SE? |
most widely used = ACARBOSE!
inhibit enzyme that breaks down dietary complex carbs to sugars. reduces quantity of glucose available for abs'n across intestinal wall. less effective - use in combination with sulphonylureas or metformin SE = not well tolerated --> abdo distension, pain, flatulence |
|
first line OHA?
|
metformin
|
|
meglitinides = ?
|
only drug = REPAGLINIDE
stimulate same R as sulphonylureas but at diff site. actions/se similar to sulphonylureas short acting take bd |
|
thiazolidinediones = ?
SE = ? |
Act on PPAR-g (peroxisome proliferator receptors) in fat cells.
can cause SUBSTANTIAL WEIGHT GAIN |
|
DPP-4 inhibitors = ?
|
Dipeptidyl dipeptidase inhibitors - they INHIBIT the activity of the enzymes that break down INCRETINS!
incretins = gut hormones GLP-1 and GIP. These incretins normally stimulate insulin-mediated glucose release from the pancreas following an oral glucose load. GLP-1 also inhibits secretion of glucagon, inhibits gastric emptying and thus delays glucose absn |
|
melatonin
|
light dark cycle regulation
sleep disorders, blind persons |
|
budenoside, ciclesonide
|
long term asthma
action of GCS |
|
fluticasone
|
long term asthma
action of GCS |
|
metyrapone
|
Dx of adrenal insufficiency, sometimes Tx of cushings
inhibits cortisol synthesis via 11 β hydroxylase |
|
what makes steroid myopathy worse?
|
9-α fluorinated corticosteroids
changing to prednisone produces improvement |
|
Prostaglandin synthetase inhibitors
|
Abnormal uterine bleeding
inhibit synthesis of prostaglandin, also interfere with myometrial prostaglandin E2 binding |
|
Tranexamic acid (antifibrinolytic)
|
Abnormal uterine bleeding
inhibit plasminogne activator |
|
Norethisterone
|
Abnormal uterine bleeding
Is a progesterone, can be used in combo or stand alone |
|
Dydrogesterone
|
Abnormal uterine bleeding
|
|
Depo Provera
|
Abnormal uterine bleeding/contraception
progesterone only contraceptive |
|
Implanon
|
inhibit ovulation
abnormal bleeding, contraception |
|
Danazol
|
abnormal uterine bleeding
inhibits endometrial proliferation causing endometrial atrophy androgenic side effects |
|
Goserelin, Nafarelin
|
(GnRH agonist)
initial agonist of pituitary, followed by 'exhaustion' --> hypogonadotrophic hypogonadism long term use complicated by decreased bone mass |